COMP <GO>
NAMS vs ZLAB // DIVIDEND YIELD & FCF PAYOUT SAFETY
NewAmsterdam Pharma Company N.V. (NASDAQ) VS. Zai Lab Limited (NASDAQ) • 15-METRIC TALLY: NAMS 3
— ZLAB 5
■ METRIC PARITY
LAST: $20.76 (-1.47%) • MKT CAP: $2.48B
dividend-safety
0.00%
LAST: $22.36 (-2.95%) • MKT CAP: $2.51B
dividend-safety
0.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NAMS VS. ZLAB)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NAMS | ZLAB | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 58.30% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -5.96% | -6.33% | +0.37 | NAMS | /fcf-yield <GO> |
| Operating Margin | -60.00% | -50.20% | -9.80 | ZLAB | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -38.40% | -21.60 | ZLAB | /net-margins <GO> |
| Revenue Growth (YoY) | -50.60% | 15.00% | -65.60 | ZLAB | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 15.94 | 0.52 | +15.42 | NAMS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 5/9 | -2.00 | ZLAB | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.6 | 42.0 | +3.60 | NAMS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.48B | $2.51B | -$28.7M | ZLAB | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NAMS REV | ZLAB REV | NAMS GROSS % | ZLAB GROSS % | NAMS FCF | ZLAB FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $22.5M | $457.2M | — | 58.3% | -$147.8M | -$158.9M |
| FY 2024 | $45.6M | $397.6M | — | 63.0% | -$158.6M | -$220.5M |
| FY 2023 | $14.1M | $266.7M | — | — | -$141.2M | -$198.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NAMS // BETA —
ZLAB // BETA —